Astellas Pharma | 4503 - Ebitda

Stock Price
2,223.00
Daily Change
72.50 3.37%
Monthly
4.37%
Yearly
49.70%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY151.7B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Astellas Pharma JPY 151.7B 11.36B Sep/2025
Chugai Pharma JPY 169.01B 12.52B Dec/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY 23.48B 14.68B Sep/2025
Kyowa Hakko Kirin JPY 32.28B 13.25B Sep/2025
M3 JPY 15.68B 7.2B Sep/2025
Otsuka Holdings JPY 193.79B 59.2B Sep/2025
Shionogi JPY 80B 35.17B Dec/2025
Sumitomo Dainippon JPY 80.4B 54.16B Sep/2025
Takeda JPY 448.13B 173.98B Dec/2025
Terumo JPY 66.76B 10.31B Sep/2025